Jafron Biomedical Co.,Ltd.’s Net Profit Rose 0.8% in First Three Quarters of 2022

Jafron Biomedical Co.,Ltd. (健帆生物科技集团股份有限公司) (300529.SZ) reported a net profit of 869.1 million yuan in the first three quarters of 2022, up 0.8% year-on-year.

Meanwhile, the company posted 2 billion yuan in revenue, up 13.7% year-on-year.

At the end of the reporting period, it had 5.1 billion yuan in total assets and 1.5 billion yuan in total liabilities, with a liability-to-asset ratio of 29.8%.